SUMMARY C-reactive protein and four other acute phase reactant proteins of non-cardiac origin (orosomucoid, alphal-antitrypsin, haptoglobin, and alpha2-macroglobulin) were studied serially by laser immunonephelometric assay in sera from 17 patients with myocardial infarction. A similar comparison was made in 57 patients undergoing surgery and 72 patients with acute infection. C-reactive protein was consistently the most sensitive acute phase reactant in all three conditions. After myocardial infarction, a raised serum C-reactive protein level was found on admission in four patients before a rise in creatine kinase MB isoenzyme (CK MB). The peak C-reactive protein level was reached on the third post-infarct day and it then declined over seven days with a half-life similar to myocardial tropomyosin. Serial monitoring of serum C-reactive protein, in parallel with cardiac proteins of short half-life (CK MB) and long half-life (tropomyosin), provides maximal information for diagnosis and for detecting post-infarct complications.
Acute phase reactant proteins are synthesised by the liver in response to acute tissue damage. Serial estimation of these proteins, C-reactive protein in particular,' has been used to monitor the progress of a variety of clinical disorders and the recent introduction of rapid assays, using laser ixmunonephelometric,2 rate immunonephelometric,3 and immunoradiometric4 techniques, will increase their clinical application.
The original observation5 that C-reactive protein could be detected in serum after myocardial infarction was followed by a number of studies using semiquantitative immunoprecipitation techniques6-9 and, later, electroimmunoprecipitation'0 and radial immunodiffusion"I assays. These studies, and a more recent immunoradiometric assay,4 indicate the potential clinical value of measuring acute phase reactants in serum after myocardial infarction. There 
Results
The mean (±SD) values for 60 healthy adults for the five acute phase reactant proteins were as follows: Creactive protein all values below 7 mg/l, orosomucoid 0.8 (+0-3) g/l, alpha,-antitrypsin 2.9 (+0.6) g/l, haptoglobin 2.0 (± 1.1) g/l, and alpha2-macroglobulin 1.7 (+ 1-0) g/l. The daily median serum levels for the 10 days after myocardial infarction in 17 patients are shown in Fig. 1 and 2 . Haptoglobin and alpha1-antitrypsin levels rose to a peak ( Fig. 1) at days 5 to 6, alpha2-macroglobulin did not reach a peak until day 8, and orosomucoid showed little change. On day 4 (Table) , these four proteins showed a rise in mean value after myocardial infarction of 33 to 127% above the mean level (expressed as 100%) for healthy adults. In contrast, C-reactive protein reached a peak level (for both mean and median) on day 3 ( Fig. 2) , the mean level being 1570% above the upper limit of the controls (7 mg/l); the corresponding day 4 mean value (Table) was increased by 1357%.
Standard curves
The haptoglobin standard curve was prepared by double diluting a normal control plasma (Behringwerke, Marburg) from 1/50 to 1/1600 in 0-9% w/v sodium chloride. A normal serum pool (Seward Immunostics) was similarly diluted from 1/25 to 1/800 for orosomucoid, from 1/100 to 1/3200 for alpha,-antitrypsin, and from 1/50 to 1/1600 for alpha2-macroglobulin.
Test sera
These were diluted, in 0.9% w/v sodium chloride, 1/300 for haptoglobin and alpha1-antitrypsin, and 1/200 for orosomucoid and alpha2-macroglobulin.
Aliquots (0.1 ml) oftest sera or diluted standard were added to 1 ml diluted antiserum or buffer (blank), mixed thoroughly by inversion, and incubated for one hour at room temperature before reading in the nephelometer according to the manufacturer's instructions.
CREATINE KINASE MB ISOENZYME Creatine kinase MB isoenzyme (CK MB) was measured at 25°C using N-acetyl cysteine-activated, immunological assay kits from Boehringer Corporation (London) Ltd. Precipath E control sera (Boehringer, Mannheim) containing known levels of CK MB isoenzyme were used to standardise the assay and the upper limit of normal was taken as 8 IU/1. (days) This large differential between the magnitude of the C-reactive protein response and those of the four other reactants was also found after hip replacement, herniorrhaphy, and infection (Table) , with viral infection showing the smallest C-reactive protein response relative to the others. Hip replacement caused the largest response for each of the five reactants. Haptoglobin, in patients with malaria, was the only reactant to fall below the mean normal value, presumably a consequence of haemolysis.
The time-scale and magnitude of the C-reactive protein response after myocardial infarction was compared with those of CK MB and tropomyosin (Fig. 2) . Raised serum levels of CK MB and tropomyosin are usually first detectable seven to eight hours after the onset of symptoms. 12 Earlier studies showed that C-reactive protein was first detectable in serum one to two days after myocardial infarction but an increase in serum level one to two hours after chest pain has been found more recently by radial inmmunodiffusion assay." We found a pre-existing increase at four hours in three of seven patients and this occurred before any rise in CK MB. Study of a larger number of patients in the immediate postinfarction period is therefore indicated. Thereafter, the mean C-reactive protein level rose in all 17 patients to a peak on day 3. This compares with a peak level at 50.5 hours in a recent study of 33 patients in whom the peak CK MB level occurred at 14.8 hours. 4 A rise in serum C-reactive protein appears to be a sensitive test for myocardial necrosis and has been detected in 49 of 50 patients with acute infarction,9 in 100 patients with infarction whenever there were significant Q wave electrocardiographic changes,8 and in all 33 patients with myocardial infarction studied serially. 4 While these results indicate good sensitivity, it is necessary to exclude obvious alternative causes of a raised serum C-reactive protein level (for example surgery, infection, arthritis) if the test is to have acceptable specificity; if this is not done, specificity will be no better than that of the erythrocyte sedimentation rate. 16 Specificity for myocardial necrosis does require to be investigated further since a few patients with congestive cardiac failure'7 and unstable angina," but not angina associated with exercise testing,4 have shown small rises in serum level. The evidence that venous thrombosis causes a false positive rise in serum Creactive protein is, however, anecdotal.6 8 
